July 14, 2016 – URI Today – Slater Commits Seed Funding to MindImmune Therapeutics, Drug Discovery Venture Targeting Neuro-Degenerative Disease
May 30, 2016 – ConvergenceRI – MindImmune, a promising new drug development firm, develops its RI roots
April 7, 2016 – Providence Journal – Neuroscience startup at URI to focus on Alzheimer’s, Parkinson’s